OSTVX
Price
$16.78
Change
+$0.09 (+0.54%)
Updated
Jan 30 closing price
Net Assets
184.34M
RLEFX
Price
$35.37
Change
+$0.24 (+0.68%)
Updated
Jan 30 closing price
Net Assets
241.03B
Ad is loading...

OSTVX vs RLEFX

Header iconOSTVX vs RLEFX Comparison
Open Charts OSTVX vs RLEFXBanner chart's image
Osterweis Growth & Income Fund
Price$16.78
Change+$0.09 (+0.54%)
VolumeN/A
Net Assets184.34M
American Funds American Balanced R5E
Price$35.37
Change+$0.24 (+0.68%)
VolumeN/A
Net Assets241.03B
OSTVX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OSTVX vs. RLEFX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSTVX is a StrongBuy and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 241B vs. OSTVX (184M). OSTVX (2.53) and RLEFX (2.42) have matching dividends . OSTVX was incepted earlier than RLEFX: OSTVX (14 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. OSTVX (33.00). RLEFX has a lower initial minimum investment than OSTVX: RLEFX (250) vs OSTVX (5000). RLEFX annual gain was more profitable for investors over the last year : 12.30 vs. OSTVX (4.46). RLEFX return over 5 years is better than : 34.94 vs. OSTVX (19.28).
OSTVXRLEFXOSTVX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years9 years-
Gain YTD2.2053.12071%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets184M241B0%
Annual Yield % from dividends2.532.42105%
Returns for 1 year4.4612.3036%
Returns for 3 years0.0615.200%
Returns for 5 years19.2834.9455%
Returns for 10 years39.04N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPAR143.293.26
+2.33%
Interparfums Inc
ACGL94.580.76
+0.81%
Arch Capital Group Ltd
DSGN4.970.03
+0.61%
Design Therapeutics
GENI8.940.04
+0.45%
Genius Sports Limited
XLO0.69-0.02
-2.88%
Xilio Therapeutics